Eliglustat CAS# 491833-29-5 依利格鲁司特
Eliglustat, also known as GENZ-112638, (trade name Cerdelga) is a treatment for Gaucher's disease developed by Genzyme Corp that was approved by the FDA August 2014. Commonly used as the tartrate salt, Eliglustat is believed to work by inhibition of glucosylceramide synthase.
📌 参考资料/链接：
Sun, Guodong; Jian, Weilin; Luo, Zhonghua; Sun, Tengfei; Li, Chao; Zhang, Jiancun; Wang, Zhongqing. Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation. Organic Process Research & Development. Volume 23. Issue 6. Pages 1204-1212. Journal; Online Computer File. (2019).
Sun, Guodong; Jian, Weilin; Luo, Zhonghua; Sun, Tengfei; Li, Chao; Zhang, Jiancun; Wang, Zhongqing. Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation. Organic Process Research & Development. Volume 23. Issue 6. Pages 1204-1212. Journal; Online Computer File. (2019).
📄 详细内容
CAS No. 491833-29-5 依利格鲁司特Eliglustat synthetic routes
Sun, Guodong; Jian, Weilin; Luo, Zhonghua; Sun, Tengfei; Li, Chao; Zhang, Jiancun; Wang, Zhongqing. Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation. Organic Process Research & Development. Volume 23. Issue 6. Pages 1204-1212. Journal; Online Computer File. (2019).
产品链接: CAS No. 491833-29-5 ››
Sun, Guodong; Jian, Weilin; Luo, Zhonghua; Sun, Tengfei; Li, Chao; Zhang, Jiancun; Wang, Zhongqing. Development of an Efficient and Scalable Asymmetric Synthesis of Eliglustat via Ruthenium(II)-Catalyzed Asymmetric Transfer Hydrogenation. Organic Process Research & Development. Volume 23. Issue 6. Pages 1204-1212. Journal; Online Computer File. (2019).
产品链接: CAS No. 491833-29-5 ››